Table 3 Percentage of nuclei stained by progesterone receptor (PgR 636) in Group A (Control) before and after 14 days (magnified 400×).
From: Effects of low-dose tamoxifen on breast cancer biomarkers Ki-67, estrogen and progesterone receptors
PATIENT | Control (before) (% stained cells) | Control (after 14 days) (% stained cells) |
|---|---|---|
1 | 49.92 | 26.45 |
2 | 63.51 | 70.84 |
3 | 33.56 | 25.98 |
4 | 98.71 | 90.29 |
5 | 85.59 | 78.36 |
6 | 66.89 | 71.24 |
7 | 78.42 | 77.25 |
8 | 50.14 | 45.89 |
9 | 0.00 | 0.00 |
10 | 16.52 | 14.81 |
11 | 0.00 | 0.00 |
12 | 100.00 | 98.89 |
13 | 95.12 | 96.48 |
14 | 91.24 | 78.25 |
15 | 17.85 | 19.25 |
16 | 80.13 | 85.64 |
17 | 25.36 | 22.84 |
18 | 15.12 | 20.98 |
19 | 22.05 | 26.97 |
20 | 100.00 | 100.00 |
MEAN | 54.51 | 52.52 |